Drug Shortage Report for MIN-OVRAL 21
Report ID | 145283 |
Drug Identification Number | 02042320 |
Brand name | MIN-OVRAL 21 |
Common or Proper name | MIN-OVRAL 21 |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL LEVONORGESTREL |
Strength(s) | 30MCG 150MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 21s |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-11-17 |
Actual start date | 2021-11-17 |
Estimated end date | 2023-01-19 |
Actual end date | 2023-01-17 |
Shortage status | Resolved |
Updated date | 2023-01-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2023-01-18 | English | Compare |
v17 | 2023-01-17 | French | Compare |
v16 | 2023-01-17 | English | Compare |
v15 | 2022-12-19 | French | Compare |
v14 | 2022-12-19 | English | Compare |
v13 | 2022-08-05 | French | Compare |
v12 | 2022-08-05 | English | Compare |
v11 | 2022-06-30 | French | Compare |
v10 | 2022-06-30 | English | Compare |
v9 | 2022-06-06 | French | Compare |
v8 | 2022-06-06 | English | Compare |
v7 | 2022-04-14 | French | Compare |
v6 | 2022-04-14 | English | Compare |
v5 | 2021-11-18 | French | Compare |
v4 | 2021-11-18 | English | Compare |
v3 | 2021-11-18 | English | Compare |
v2 | 2021-09-07 | French | Compare |
v1 | 2021-09-07 | English | Compare |
Showing 1 to 18 of 18